CompuMed, Inc.
CMPD · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $5 | $3 |
| - Cash | $1 | $1 | $2 | $1 |
| + Debt | $1 | $0 | $1 | $0 |
| Enterprise Value | $4 | $4 | $4 | $2 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 12.1% | 2.9% | -1.6% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 45.4% | 46.8% | 47.3% | 48.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 15.9% | 12.5% | 13.5% | 17.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 3.1% | 1.4% | 1.8% | 6.1% |
| EPS Diluted | 0.044 | 0.017 | 0.023 | 0.077 |
| % Growth | 158.1% | -24.2% | -70.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $1 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |